503-222-1261 info@crgpdx.com

Hypertension

This is a study to evaluate the safety and efficacy of a study drug vs. placebo in patients with essential hypertension who are not adequately controlled by standard of care.  The study will last approximately 1 year and includes all study related care including the completion of 24 hour ambulatory blood pressure monitoring (ABPMs) at predetermined time points.  Financial compensation of up to $1525.00 is available for patients who complete the entire study.  The estimated start date for this study is October of 2017.